Investors Alert: PharmAthene, the Goldfield Corporation, Excel Maritime Carriers Ltd, Pacific Biosciences of California

Dallas, TX -- (SBWIRE) -- 03/12/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

PharmAthene, Inc. (NYSEAMEX:PIP) shares gained 11.11% to $1.80. Aegis Capital initiated coverage on PIP on Mar. 6 to Buy. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats.

Is PIP a Strong Buy After The Recent Gain? Let’s Find out Here

The Goldfield Corporation (NYSEAMEX:GV) shares increased 10.25% and closed at $4.84. The 52 week trading range for the company is $0.61 - $4.19. The company is engaged in electrical construction, including (the placement of fiber optic cable) and real estate development. The electrical construction operation serves electric utilities and industrial companies throughout much of the United States.

Is GV a Strong Buying Opportunity After The Recent Slump? Find out Here

Excel Maritime Carriers Ltd (NYSE:EXM) shares climbed 9.85% to $0.714. The 52 week trading range for the company is $0.36 - $2.29. The company is engaged in providing worldwide sea borne transportation services for drybulk cargo including, among others, iron ore, coal and grain, collectively referred to as major bulks, and steel products, fertilizers, cement, bauxite, sugar and scrap metal, collectively referred to as minor bulks.

Should Investors Consider EXM After The Recent price Action? Get Free Trend Analysis Here

Pacific Biosciences of California (NASDAQ:PACB) shares gained 9.28% to $2.59. The company, on Feb. 5, announced that it has entered into an agreement with entities affiliated with Deerfield Management Company, L.P. (Deerfield), a leading healthcare investment organization and significant Pacific Biosciences stockholder, pursuant to which Deerfield provided Pacific Biosciences with $20.5 million in debt financing.

Should Investors Consider PACB After The Recent price Action? Get Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.